280E Updates: Rescheduling, Amending Returns, and Why Timing Matters - Sign up for our free webinar now!

280E Updates: Rescheduling, Amending Returns, and Why Timing Matters - Sign up for our free webinar now!

Increasing Profits | Cannabis Business Times

Sign in or create a free Cannabis Business Times account to continue reading

Continue to Site »
Site will load in 15 seconds

Continue to Site »X

Increasing Profits

Learn how cannabis companies have utilized the industry’s most innovative products and technology to increase yields and boost their bottom lines.

February 6, 2018

Adobe Stock 96990932 Fmt — Adobe Stock

Humidity Control

8th Annual ‘Best Cannabis Companies to Work For’ Now Open for Entries

PleoPharma Announces 1st Patient Dosed in Phase 3 Clinical Trial for Cannabis Use Disorder

Best Cannabis Companies to Work For

How to Turn LED Lighting Into a Strategic Cultivation Tool

Sens. Ted Budd and Pete Ricketts' Hemp Product Ban Amendment

NMAI Letter RE: Final Determination Regarding Idaho Medical Cannabis Act Initiative Petition

What Is Certified Human-Composed Creation and Why Is It Important?

Massachusetts State Ballot Law Commission Ruling on Cannabis Petition - July 21, 2026

NDASA and MMJ Response to DOJ's Schedule III Stay Opposition - July 16, 2026

Image Distillate

Image Trimmer Test

Massachusetts State Ballot Law Commission Notice of Hearing 26-06 - July 2026

Kevin Gilnack Objection to Massachusetts Cannabis Petition Filed With State Ballot Law Commission -- July 8, 2026

Massachusetts Elections Division Letter to Coalition for a Healthy Massachusetts - July 9, 2026

DOJ Response Opposing NDASA/MMJ's Motion to Stay Schedule III Order

PleoPharma Announces 1st Patient Dosed in Phase 3 Clinical Trial for Cannabis Use Disorder

The trial of PP-01 (CAN-004) advances an investigational, once-daily therapy for withdrawal symptoms in patients with cannabis use disorder.

Page 1 of 10